The Greater Pennsylvania chapter of the Alzheimer’s Association says it’s been a productive and exciting year when it comes ...

When we think about dementia, we often think of a person experiencing memory loss and confusion. While it’s true that these ...

SCIENTISTS investigating Alzheimer’s disease have made a key breakthrough, identifying a key cellular process that drives ...

Although we don't know a lot about the causes of Alzheimer's disease, the following conditions may raise your risk.

Axsome Therapeutics said it would submit its Alzheimer’s disease treatment for FDA approval despite mixed results from two ...

INmune Bio's XPro targets neuroinflammation, showing promising biomarker results in Alzheimer's, with a potential to ...

Even as new drugs come to market, further study appears to point to infections as a possible cause for the debilitating ...

A recent study published in Neurology explored whether high doses of nicotinamide, a derivative of vitamin B3, could reduce a ...

Spread the loveA new Alzheimer’s treatment has shown unprecedented success in late-stage clinical trials, offering hope to ...

As the year comes to a close, experts from the Alzheimer's Association reflect on some of the hopeful advances in diagnosis, ...

The 2024 update to the nation’s roadmap of strategies and actions to address Alzheimer’s disease was released Wednesday by the US Department of Health and Human Services, highlighting federal approval ...

Common Heart Drug May Slow Progression of Huntington's Disease Dec. 2 ... Learning Reveals Behaviors Linked With Early Alzheimer's, Points to New Treatments Nov. 26, 2024 — Scientists used ...